'Someone should oversee it': Patient perspectives on the ethical issues arising with the regulation of probiotics

Health Expectations

Volumn 18, Issue 2, 2015, Pages 250-261

  Harrison, Krista L ^a,b   Farrell, Ruth M ^c   Brinich, Margaret A ^c   Highland, Janelle ^c   Mercer, Marybeth ^c   Mccormick, Jennifer B ^d   Tilburt, Jon ^d   Geller, Gail ^e   Marshall, Patricia ^f   Sharp, Richard R ^c,f  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioethics; Government regulation; Metagenome; Probiotics; Qualitative research

Indexed keywords

PROBIOTIC AGENT;

ATTITUDE TO HEALTH; CHRONIC DISEASE; CLINICAL TRIAL; FEMALE; GASTROINTESTINAL DISEASE; GOVERNMENT REGULATION; HUMAN; INFORMATION PROCESSING; MALE; MULTICENTER STUDY; PERCEPTION; PSYCHOLOGY; SOCIOECONOMICS; TERTIARY CARE CENTER; UNITED STATES;

CHRONIC DISEASE; FEMALE; FOCUS GROUPS; GASTROINTESTINAL DISEASES; GOVERNMENT REGULATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; PERCEPTION; PROBIOTICS; SOCIOECONOMIC FACTORS; TERTIARY CARE CENTERS; UNITED STATES;

EID: 84925357813     PISSN: 13696513     EISSN: 13697625     Source Type: Journal    
DOI: 10.1111/hex.12027     Document Type: Article

References (26)

1. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The Human Microbiome Project. Nature, 2007; 449: 804-810.
2. Peterson J, Garges S, Giovanni M et al. The NIH Human Microbiome Project. Genome Research, 2009; 19: 2317-2323.
3. Canadian Institutes of Health Research. Canadian Microbiome Initiative. 2009. Available at: http://www.researchnet-recherchenet.ca/rnr16/vwOpprtntyDtls.do?prog=793&tag=1, accessed 27 August 2012.
4. Anon . MicroObes - Human Intestinal Microbiome in Obesity and Nutritional Transition. 2008. Available at: http://www.inra.fr/micro_obes_eng/, accessed 27 August 2012.
5. Anon. International Human Microbiome Consortium Research Programs. Available at: http://www.human-microbiome.org/index.php?id=30, accessed 30 August 2011.
6. Kinross JM, Darzi AW, Nicholson JK. Gut microbiome-host interactions in health and disease. Genome Medicine, 2011; 3: 14.
7. Turnbaugh PJ, Stintzi A. Human health and disease in a microbial world. Front Microbiology, 2011; 2: 190.
8. FAO/WHO Working Group. Guidelines for the Evaluation of Probiotics in Food. London Ontario, Canada; 2002. Available at: http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/, accessed 22 April 2011.
9. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutrition, 2011; 6: 209-240.
10. Huffnagle GB, Wernick S. The Probiotics Revolution: The Definitive Guide to Safe, Natural Health Solutions Using Probiotic and Prebiotic Foods and Supplements. 1st edn. Bantam Dell: New York, NY, 2007.
11. Cain AM, Karpa KD. Clinical utility of probiotics in inflammatory bowel disease. Alternative Therapies in Health and Medicine, 2011; 17: 72-79.
12. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Systematic Revolution, 2011; 11: CD004827.
13. Meijer BJ, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. Journal of Clinical Gastroenterology, 2011; 45 (Suppl): S139-S144.
14. Frech TM, Khanna D, Maranian P, Frech EJ, Sawitzke AD, Murtaugh MA. Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention. Clinical and Experimental Rheumatology, 2011; 2 (Suppl. 65): S22-S25.
15. Wallace TC, Guarner F, Madsen K et al. Human gut microbiota and its relationship to health and disease. Nutrition Reviews, 2011; 69: 392-403.
16. Mercer M, Brinich MA, Geller G et al. How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome. Journal of Clinical Gastroenterology, 2012; 46: 138-144. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21716123, accessed 29 August 2011.
17. QSR International Pty Ltd. NVivo qualitative data analysis software.; 2008. Available at: http://www.qsrinternational.com/products_nvivo.aspx, accessed 21 September 2010.
18. Corbin JM, Strauss AC.Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. 3rd edn. Thousand Oaks, CA: Sage Publications, Inc, 2007.
19. IBM Corporation. SPSS for Windows. Somers, NY: IMB Corporation, 2007.
20. Hasler CM, Brown AC. Position of the American Dietetic Association: functional foods. Journal of American Dietetic Association, 2009; 109: 735-746.
21. §201(p)(1) [21 USC 321(p)(1)]. Federal Food Drug and Cosmetic Act.
22. Hoffman FA, Heimbach JT, Sanders ME, Hibberd PL. Executive summary: scientific and regulatory challenges of development of probiotics as foods and drugs. Clinical Infectious Disease, 2008; 46: S53-S57.
23. Joos S. Review on efficacy and health services research studies of complementary and alternative medicine in inflammatory bowel disease. Chinese Journal of Integrative Medicine, 2011; 17: 403-409.
24. Condit CM. Public attitudes and beliefs about genetics. Annual Revolution of Genomics and Human Genetics, 2010; 11: 339-359.
25. Wynne B. Creating public alienation: expert cultures of risk and ethics on GMOs. Science as Culture (London), 2001; 10: 445-481.
26. Lang JT, Hallman WK. Who does the public trust? The case of genetically modified food in the United States Risk Analysis, 2005; 25: 1241-1252.